Vertex Pharmaceuticals
VRTX
#155
Rank
HK$1.035 T
Marketcap
HK$4,082
Share price
-2.94%
Change (1 day)
24.52%
Change (1 year)

EPS for Vertex Pharmaceuticals (VRTX)

EPS in 2026 (TTM): HK$122.59

According to Vertex Pharmaceuticals's latest financial reports the company's current EPS (TTM) is HK$122.86. In 2025 the company made an earnings per share (EPS) of HK$121.29 an increase over its 2024 EPS that were of -HK$16.15.

EPS history for Vertex Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$122.591.07%
2025HK$121.29-850.97%
2024-HK$16.15-114.67%
2023HK$110.088.17%
2022HK$101.7742.64%
2021HK$71.35-12.67%
2020HK$81.70128.01%
2019HK$35.83-44.54%
2018HK$64.61670.09%
2017HK$8.39-327.66%
2016-HK$3.69-79.65%
2015-HK$18.11-26.43%
2014-HK$24.6253.92%
2013-HK$15.99316.33%
2012-HK$3.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.37-57.37%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$45.88-62.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-HK$24.31-119.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$7.79-93.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$35.44-71.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-HK$18.90-115.38%๐Ÿ‡บ๐Ÿ‡ธ USA